T. Rowe Price Associates’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-2,330,434
| Closed | -$84.8M | – | 2625 |
|
|
2016
Q4 | $84.8M | Sell |
2,330,434
-155,840
| -6% | -$5.67M | 0.02% | 644 |
|
|
2016
Q3 | $94.9M | Buy |
2,486,274
+1,158,959
| +87% | +$44.2M | 0.02% | 590 |
|
|
2016
Q2 | $10.8M | Sell |
1,327,315
-800
| -0.1% | -$6.54K | ﹤0.01% | 1275 |
|
|
2016
Q1 | $8.23M | Sell |
1,328,115
-19,780
| -1% | -$123K | ﹤0.01% | 1312 |
|
|
2015
Q4 | $11.3M | Sell |
1,347,895
-7,940
| -0.6% | -$66.5K | ﹤0.01% | 1256 |
|
|
2015
Q3 | $5.25M | Buy |
1,355,835
+82,245
| +6% | +$318K | ﹤0.01% | 1427 |
|
|
2015
Q2 | $11.3M | Buy |
+1,273,590
| New | +$11.3M | ﹤0.01% | 1314 |
|